Delivery Order SPE2DB22D2206-SPE2DB25FJK78
- Not listed
- The Defense Logistics Agency awarded a $2,515.44 delivery order to AmerisourceBergen Drug Corp for 100 capsules of MYDAYIS ER 25 mg on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply performed at the contractor's Conshohocken, Pennsylvania location. MYDAYIS is an extended-release amphetamine-based medication used in the treatment of attention deficit hyperactivity disorder (ADHD). This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYDAYIS ER 25 mg capsules (100-count units) valued at $1,061.94 under a firm fixed price contract. This non-set-aside delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYDAYIS is a prescription amphetamine-based medication used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Mydayis ER 50 mg capsules (100-count units) with a ceiling value of $1,445.74. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competitive procurement. The order is scheduled for completion by September 22, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mydayis ER 12.5 mg capsules (100 count) with a ceiling value of $3,185.52. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,773.28 to AmerisourceBergen Drug Corp for 100 capsules of MYDAYIS ER 50 mg, a prescription medication used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters....
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,551.53 to AmerisourceBergen Drug Corp for Mydayis capsules 12.5mg on September 19, 2025, with completion expected by September 22, 2025. This firm fixed-price delivery order represents a pediatric attention-deficit/hyperactivity disorder medication procurement supporting federal medical operations. The award utilized no set-aside designation, indicating competitive award of this pharmaceutical delivery through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,672.80 firm-fixed-price contract is for the supply of MYDAYIS CAPS 37.5MG, a prescription medication. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen, through its Corporate Office division, is a significant provider of pharmaceuticals and medical supplies to the U.S. federal...
- This is a $1,205.64 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MYDAYIS CAPS 25MG pharmaceutical product. This order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025 for the delivery of a broad range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.67 firm fixed-price delivery order is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of April 25, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $553.51 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 100 capsules of MYDAYIS ER 50 MG CAPSULE. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from September 15, 2023 through September 18, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency Troop Support Medical supports...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJK78Delivery Order
The Defense Logistics Agency awarded a $1,036.20 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mydayis ER 50 mg capsules (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mydayis is an extended-release formulation used in the treatment of attention-deficit/hyperactivity disorder and represents part of the company's broader pharmaceutical supply portfolio to federal healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp has demonstrated consistent capability in competitively awarded federal medical procurement, serving critical customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/14/25 |